These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 10912165)

  • 1. [Recent fluoroquinolones. Highly effective weapons for ambulatory therapy].
    Stahlmann R; Lode H
    MMW Fortschr Med; 1999 Nov; 141(47):35-6. PubMed ID: 10912165
    [No Abstract]   [Full Text] [Related]  

  • 2. [Respiratory tract infections. Increasingly more established antibiotics fail].
    MMW Fortschr Med; 2002 Oct; 144(42):65. PubMed ID: 12534005
    [No Abstract]   [Full Text] [Related]  

  • 3. [Oral fluoroquinolones. Rational antibiosis as needed].
    MMW Fortschr Med; 1999 Sep; 141(35):58-9. PubMed ID: 10897964
    [No Abstract]   [Full Text] [Related]  

  • 4. [Fluoroquinolones--a current review].
    Christ W; Kemmler H
    Med Monatsschr Pharm; 2001 Jul; 24(7):215-25. PubMed ID: 11486553
    [No Abstract]   [Full Text] [Related]  

  • 5. The fluoroquinolones after ciprofloxacin and ofloxacin.
    Hooper DC
    Curr Clin Top Infect Dis; 2000; 20():63-91. PubMed ID: 10943519
    [No Abstract]   [Full Text] [Related]  

  • 6. [Moxifloxacin--a novel antimicrobial preparation for treatment of respiratory infections].
    Iakovlev SV; Polushkina NR; Iakovlev VP
    Ter Arkh; 2001; 73(11):15-22. PubMed ID: 11806197
    [No Abstract]   [Full Text] [Related]  

  • 7. Prescribing considerations in fluoroquinolone therapy.
    Gentry LO
    Pharmacotherapy; 1993; 13(2 Pt 2):39S-44S. PubMed ID: 8474937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment in general practice. Effective, well tolerated therapy].
    MMW Fortschr Med; 2000 Sep; 142(37):58-9. PubMed ID: 11026226
    [No Abstract]   [Full Text] [Related]  

  • 9. Fluoroquinolones.
    Molavi A
    Am Fam Physician; 1988 May; 37(5):279-84. PubMed ID: 3284309
    [No Abstract]   [Full Text] [Related]  

  • 10. New uses for new and old quinolones and the challenge of resistance.
    Hooper DC
    Clin Infect Dis; 2000 Feb; 30(2):243-54. PubMed ID: 10671323
    [No Abstract]   [Full Text] [Related]  

  • 11. Choosing the ideal antibiotic therapy and the role of the newer fluoroquinolones in respiratory tract infections.
    Owens RC
    Am J Manag Care; 2000 May; 6(8 Suppl):S442-7. PubMed ID: 10977484
    [No Abstract]   [Full Text] [Related]  

  • 12. Activity of levofloxacin, ofloxacin, D-ofloxacin and ciprofloxacin against systemic and respiratory tract infections in laboratory animals.
    Klesel N; Geweniger KH; Koletzki P; Isert D; Limbert M; Markus A; Riess G; Schramm H; Seibert G; Iyer P
    Drugs; 1995; 49 Suppl 2():211-4. PubMed ID: 8549307
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of the fluoroquinolones in primary care practice.
    Harding GK
    Clin Invest Med; 1989 Feb; 12(1):71-3. PubMed ID: 2920484
    [No Abstract]   [Full Text] [Related]  

  • 14. [Other communal respiratory pathogens and new fluoroquinolones].
    Cantón R; Loza E; Valdezate S; Baquero F
    Enferm Infecc Microbiol Clin; 1998 Dec; 16 Suppl 2():12-21; discussion 47-52. PubMed ID: 10344094
    [No Abstract]   [Full Text] [Related]  

  • 15. [Tested and new chemotherapy in infectious diseases].
    Hoigné R; Keller MF
    Schweiz Med Wochenschr; 1972 Jul; 102(27):933-40. PubMed ID: 4558901
    [No Abstract]   [Full Text] [Related]  

  • 16. Newer fluoroquinolones and the management of respiratory tract infections.
    Karchmer AW
    Clin Infect Dis; 2000 Aug; 31 Suppl 2():S15. PubMed ID: 10984322
    [No Abstract]   [Full Text] [Related]  

  • 17. Respiratory fluoroquinolones: differences in the details.
    Mandell LA; Iannini PB; Tillotson GS
    Clin Infect Dis; 2004 May; 38(9):1331-2; author reply 1332-3. PubMed ID: 15127351
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experiences with septrin therapy of severe bacterial respiratory infections].
    Sassy-Dobray G; Miczbán I; Katona K; Lukács J; Gyöngyösi I; Sebök L
    Orv Hetil; 1971 Dec; 112(51):3073-7. PubMed ID: 5136650
    [No Abstract]   [Full Text] [Related]  

  • 19. Treating respiratory tract infections in ambulatory care in Belgium: fluoroquinolone consumption and resistance development.
    Simoens S; Verhaegen J; Laekeman G; Peetermans WE
    Int J Antimicrob Agents; 2005 Jul; 26(1):62-8. PubMed ID: 15963695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significant role of newer quinolone antimicrobials in respiratory tract infection: focused on sparfloxacin].
    Jpn J Antibiot; 1994 Oct; 47(10):1241-58. PubMed ID: 7807686
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.